Development Level

Tchem 2 | 1,890
Tclin 1 | 602

Disease

Autistic Disorder 3 | 320
psoriasis 3 | 6,685
Alzheimer's disease 2 | 644
Atopic dermatitis 2 | 944
Breast cancer 2 | 3,094
Cancer 2 | 2,346
Dementia 2 | 129
Endometriosis 2 | 535
Huntington's disease 2 | 72
Hyperandrogenism 2 | 32
Hypertension 2 | 287
Hypertensive disease 2 | 193
Hypogonadism 2 | 70
Hypopituitarism 2 | 36
Infertility 2 | 163
Inflammatory bowel disease 2 | 142
Klinefelter's syndrome 2 | 59
Mammary Neoplasms 2 | 410
Muscular atrophy 2 | 67
Neurodegenerative disease 2 | 383
Neuropathy 2 | 210
Obesity 2 | 616
Polycystic Ovary Syndrome 2 | 332
Prostatic Neoplasms 2 | 471
Rosacea 2 | 18
Withdrawal disorder 2 | 19
astrocytic glioma 2 | 2,241
diabetes mellitus 2 | 1,663
group 4 medulloblastoma 2 | 1,875
interstitial cystitis 2 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
malignant mesothelioma 2 | 3,162
ovarian cancer 2 | 8,484
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
Acne 1 | 20
Allergic conjunctivitis 1 | 25
Androgen insensitivity syndrome 1 | 11
Anovulation 1 | 20
Anxiety Disorders 1 | 37
Anxiety disorder 1 | 22
Aplastic anemia 1 | 18
Cardiomegaly 1 | 66
Complex regional pain syndrome 1 | 12
Congenital hypoplastic anemia 1 | 8
Corneal abrasion 1 | 6
Corneal ulcer 1 | 9
Craniopharyngioma 1 | 13
Cyclitis 1 | 6
Demyelinating Diseases 1 | 7
Diabetic Cardiomyopathies 1 | 10
Diabetic Retinopathy 1 | 53
Diaphragmatic Hernia 1 | 40
Diffuse idiopathic skeletal hyperostosis 1 | 6
Donohue Syndrome 1 | 6
Eating disorder 1 | 24
Female Urogenital Diseases 1 | 18
Gestational Diabetes 1 | 17
Goiter 1 | 27
Graves' disease 1 | 25
Gynecomastia 1 | 13
Herpes zoster keratitis 1 | 6
Hormone receptor positive malignant neoplasm of breast 1 | 10
Hyperactive behavior 1 | 31
Hyperglycemia 1 | 120
Hyperinsulinism 1 | 63
Hyperprolactinemia 1 | 22
Hyperthyroidism 1 | 50
Hypogonadotropic hypogonadism 1 | 4
Hypospadias 1, X-Linked 1 | 2
Insulin Resistance 1 | 48
Iridocyclitis 1 | 12
Iritis 1 | 9
Keratopathy 1 | 12
Kidney Failure, Chronic 1 | 45
Laron syndrome 1 | 9
Malignant tumor of prostate 1 | 11
McCune Albright syndrome 1 | 19
Metabolic Bone Disorder 1 | 11
Metabolic acidosis 1 | 49
Metastatic Prostate Carcinoma 1 | 18
Pituitary Neoplasms 1 | 6
Post-Op Ocular Inflammation 1 | 10
Precocious puberty 1 | 4
Prostatic Intraepithelial Neoplasias 1 | 11
Prostatic hypertrophy 1 | 9
Pseudohermaphroditism 1 | 16
Pulmonary Fibrosis 1 | 66
Punctate Epithelial Keratopathy 1 | 6
Retinopathy of prematurity 1 | 21
Rhinitis 1 | 46
Short bowel syndrome 1 | 16
Silver-Russell syndrome 1 | 37
Skin disease 1 | 65
Sleep apnea 1 | 7
Spinocerebellar ataxia type 23 1 | 2
Uterine fibroid 1 | 29
Uveitis 1 | 103
protein-energy malnutrition 1 | 8

Tissue

Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Nervous System 3 | 18,561
Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Digestive Tract 2 | 18,473
Liver and Pancreas 2 | 18,136
Male tissues 2 | 17,969
Respiratory system 2 | 17,484
Skin and soft tissues 2 | 18,115
Urinary Tract 2 | 18,444

Target Family

Non-IDG 2 | 11,971
Nuclear Receptor 1 | 48

Grant Application

5R01MH039917-19 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Androgen receptor AR Tclin Nuclear Receptor -3.78107 6683.7 1366
Insulin-like growth factor I IGF1 Tchem Non-IDG -4.29982 21900.3 689
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86